CXCL16 is a novel scavenger receptor on platelets and is associated with acute coronary syndrome

Thrombosis and Haemostasis

Volumn 105, Issue 6, 2011, Pages 1112-1114

  Seizer, Peter ^a   Stellos, Konstantinos ^a   Selhorst, Gerhard ^a   Krämer, Björn F ^a   Lang, Michael R ^a   Gawaz, Meinrad ^a   May, Andreas E ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIVITAMIN K; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CLOPIDOGREL; CREATINE KINASE; CXCL16 CHEMOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE;

ACUTE CORONARY SYNDROME; AGED; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; EXTRACELLULAR SPACE; FEMALE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SECRETION; STABLE ANGINA PECTORIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE MEMBRANE; UPREGULATION;

ACUTE CORONARY SYNDROME; ADENOSINE DIPHOSPHATE; AGED; AGED, 80 AND OVER; ANTIBODIES, BLOCKING; BLOOD PLATELETS; CHEMOKINES, CXC; FEMALE; HUMANS; INFLAMMATION; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; PLATELET ACTIVATION; PROTEIN BINDING; RECEPTORS, SCAVENGER;

EID: 79958128409     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH10-10-0689     Document Type: Letter

References (14)

1. Seizer P, Gawaz M, May AE. Platelet-monocyte interactions--a dangerous liaison linking thrombosis, inflammation and atherosclerosis. Curr Med Chem 2008; 15: 1976-1980.
2. Siegel-Axel D, Daub K, Seizer P, Lindemann S, et al. Platelet lipoprotein interplay: trigger of foam cell formation and driver of atherosclerosis. Cardiovasc Res 2008; 78: 8-17.
3. Shashkin P, Dragulev B, Ley K. Macrophage differentiation to foam cells. Curr Pharm Des 2005; 11: 3061-3072.
4. Seizer P, Schonberger T, Schott M, et al. EMMPRIN and its ligand cyclophilin A regulate MT1-MMP, MMP-9 and M-CSF during foam cell formation. Atherosclerosis 2010; 209: 51-57.
5. Chen M, Kakutani M, Naruko T, et al. Activationdependent surface expression of LOX-1 in human platelets. Biochem Biophys Res Commun 2001; 282: 153-158.
6. Korporaal SJ, Van EM, Adelmeijer J, et al. Platelet activation by oxidized low density lipoprotein is mediated by CD36 and scavenger receptor-A. Arterioscler Thromb Vasc Biol 2007; 27: 2476-2483.
7. Valiyaveettil M, Podrez EA. Platelet hyperreactivity, scavenger receptors and atherothrombosis. J Thromb Haemost 2009; 7 (Suppl 1): 218-221.
8. Shimaoka T, Nakayama T, Fukumoto N, et al. Cell surface-anchored SR-PSOX/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cells. J Leukoc Biol 2004; 75: 267-274.
9. Shimaoka T, Kume N, Minami M, et al. Molecular cloning of a novel scavenger receptor for oxidized low density lipoprotein, SR-PSOX, on macrophages. J Biol Chem 2000; 275: 40663-40666.
10. Matloubian M, David A, Engel S, et al. A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat Immunol 2000; 1: 298-304.
11. Ludwig A, Weber C. Transmembrane chemokines: versatile 'special agents' in vascular inflammation. Thromb Haemost 2007; 97: 694-703.
12. Yamauchi R, Tanaka M, Kume N, et al. Upregulation of SR-PSOX/CXCL16 and recruitment of CD8+ T cells in cardiac valves during inflammatory valvular heart disease. Arterioscler Thromb Vasc Biol 2004; 24: 282-287.
13. Lehrke M, Millington SC, Lefterova M, et al. CXCL16 is a marker of inflammation, atherosclerosis, and acute coronary syndromes in humans. J Am Coll Cardiol 2007; 49: 442-449.
14. Stellos K, Bigalke B, Stakos D, et al. Platelet-bound P-selectin expression in patients with coronary artery disease: impact on clinical presentation and myocardial necrosis, and effect of diabetes mellitus and anti-platelet medication. J Thromb Haemost 2010; 8: 205-207.